{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:26:28Z","timestamp":1793319988523,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007184","name":"Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY011289"],"award-info":[{"award-number":["R01-EY011289"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013779","name":"Retina Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ajo.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T13:29:19Z","timestamp":1592659759000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Macular and Peripapillary Optical Coherence Tomography Angiography Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data"],"prefix":"10.1016","volume":"219","author":[{"given":"Eugenia","family":"Custo Greig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Brigell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Moult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-4357","authenticated-orcid":false,"given":"James G.","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajo.2020.06.009_bib1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.drudis.2019.03.028","article-title":"Recent advances in the management of diabetic retinopathy","volume":"24","author":"Dulull","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ajo.2020.06.009_bib2","doi-asserted-by":"crossref","first-page":"582060","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy: vascular and inflammatory disease","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajo.2020.06.009_bib3","series-title":"Preferred Practice Guidelines. Diabetic Retinopathy","year":"2016"},{"issue":"2","key":"10.1016\/j.ajo.2020.06.009_bib4","first-page":"233","article-title":"Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report #18","volume":"39","author":"Davis","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2020.06.009_bib5","first-page":"834","article-title":"Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.06.009_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ophtha.2014.08.048","article-title":"Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy","volume":"122","author":"Ip","year":"2015","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.06.009_bib7","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10792-019-01076-x","article-title":"Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy","volume":"39","author":"Sorour","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2020.06.009_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0161-6420(91)32165-1","article-title":"Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study","volume":"98","author":"Kwiterovich","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.06.009_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","article-title":"Optical coherence tomography angiography","volume":"64","author":"Spaide","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2020.06.009_bib10","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/IAE.0000000000000716","article-title":"Optical coherence tomography angiography features of diabetic retinopathy","volume":"35","author":"Hwang","year":"2015","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2020.06.009_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamaophthalmol.2016.0600","article-title":"Select features of diabetic retinopathy on swept-source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes","volume":"134","author":"Salz","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2020.06.009_bib12","first-page":"1545","article-title":"Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography","volume":"10","author":"Mastropasqua","year":"2017","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.06.009_bib13","doi-asserted-by":"crossref","first-page":"BIO307","DOI":"10.1167\/iovs.17-21787","article-title":"Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography","volume":"58","author":"Nesper","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2020.06.009_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ophtha.2019.06.016","article-title":"OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: a prospective study","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.06.009_bib15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2020.06.009_bib16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/IAE.0000000000002671","article-title":"Distinguishing intraretinal microvascular abnormalities from retinal neovascularization using optical coherence tomography angiography","volume":"40","author":"Arya","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.06.009_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2019.03.008","article-title":"Impact of Binarization thresholding and brightness\/contrast adjustment methodology on optical coherence tomography angiography image quantification","volume":"205","author":"Mehta","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2020.06.009_bib18","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1097\/IAE.0000000000002328","article-title":"Peripapillary neurovascular coupling in the early stages of diabetic retinopathy","volume":"39","author":"Rodrigues","year":"2019","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2020.06.009_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"10","key":"10.1016\/j.ajo.2020.06.009_bib20","doi-asserted-by":"crossref","first-page":"e0205773","DOI":"10.1371\/journal.pone.0205773","article-title":"Comparison of methods to quantify macular and peripapillary vessel density in optical coherence tomography angiography","volume":"13","author":"Rabiolo","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2020.06.009_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3341\/kjo.2019.0113","article-title":"Macular microvasculature in high myopia without pathologic changes: an optical coherence tomography angiography study","volume":"34","author":"Min","year":"2020","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.06.009_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.8.4.14","article-title":"Peripapillary region perfusion and retinal nerve fiber layer thickness abnormalities in diabetic retinopathy assessed by OCT angiography","volume":"8","author":"Liu","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.ajo.2020.06.009_bib23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1167\/iovs.12-11158","article-title":"Association between myopia and glaucoma in the United States population","volume":"54","author":"Qiu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2020.06.009_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2020.06.009_bib25","series-title":"R: A language and environment for statistical computing [computer program]","year":"2012"},{"key":"10.1016\/j.ajo.2020.06.009_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/OPTH.S182420","article-title":"Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab","volume":"13","author":"Shakarchi","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.06.009_bib27","first-page":"535","article-title":"Anti-VEGF therapy for diabetic eye diseases","volume":"6","author":"Bahrami","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ajo.2020.06.009_bib28","doi-asserted-by":"crossref","first-page":"212532","DOI":"10.7573\/dic.212532","article-title":"The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy","volume":"7","author":"Zhao","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.ajo.2020.06.009_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2017.05.020","article-title":"The United Kingdom diabetic retinopathy electronic medical record users group: report 3: baseline retinopathy and clinical features predict progression of diabetic retinopathy","volume":"180","author":"Lee","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2020.06.009_bib30","first-page":"823","article-title":"Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2020.06.009_bib31","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1097\/IAE.0000000000000849","article-title":"Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography","volume":"35","author":"Takase","year":"2015","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2020.06.009_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.eye.6701456","article-title":"Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment","volume":"19","author":"Conrath","year":"2005","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2020.06.009_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ophtha.2016.10.008","article-title":"Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity","volume":"124","author":"Samara","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.06.009_bib34","first-page":"S5","article-title":"Parafoveal retinal vessel density assessment by optical coherence tomography angiography in healthy eyes","volume":"49","author":"Arya","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"10","key":"10.1016\/j.ajo.2020.06.009_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00592-018-1202-3","article-title":"Optical coherence tomography angiography findings of neurovascular changes in type 2 diabetes mellitus patients without clinical diabetic retinopathy","volume":"55","author":"Li","year":"2018","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.ajo.2020.06.009_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00592-019-01288-8","article-title":"Do microvascular changes occur preceding neural impairment in early-stage diabetic retinopathy? Evidence based on the optic nerve head using optical coherence tomography angiography","volume":"56","author":"Li","year":"2019","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.ajo.2020.06.009_bib37","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ajo.2013.05.033","article-title":"Predictive factors for the progression of diabetic macular ischemia","volume":"156","author":"Sim","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2020.06.009_bib38","doi-asserted-by":"crossref","first-page":"15814","DOI":"10.1038\/s41598-019-52354-8","article-title":"Peripapillary microvasculature in patients with diabetes mellitus: An optical coherence tomography angiography study","volume":"9","author":"Shin","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ajo.2020.06.009_bib39","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1097\/IAE.0000000000001458","article-title":"Variability in foveal avascular zone and capillary density using optical coherence tomography angiography machines in healthy eyes","volume":"37","author":"Magrath","year":"2017","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2020.06.009_bib40","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1038\/s41598-017-09255-5","article-title":"Reproducibility and differences in area of foveal avascular zone measured by three different optical coherence tomographic angiography instruments","volume":"7","author":"Shiihara","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ajo.2020.06.009_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3928\/23258160-20180628-04","article-title":"Quantitative comparison of retinal vascular features in optical coherence tomography angiography images from three different devices","volume":"49","author":"Anegondi","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ajo.2020.06.009_bib42","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00417-020-04716-6","article-title":"Repeatability and reproducibility of vessel density measurements on optical coherence tomography angiography in diabetic retinopathy","volume":"258","author":"Levine","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420302956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420302956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:41:55Z","timestamp":1762080115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420302956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":42,"alternative-id":["S0002939420302956"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.06.009","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macular and Peripapillary Optical Coherence Tomography Angiography Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}